article thumbnail

Turning Science into Business: Commercialising CRISPR

Drug Discovery World

While attending Life Science Baltics 2023, Diana Spencer spoke to Monika Paule , CEO and Co-founder of Caszyme, about creating a company based on CRISPR gene editing and some of the challenges of operating in this dynamic area of research. Caszyme was founded in 2017 by the pioneers of CRISPR gene editing technologies.

Science 263
article thumbnail

Bios launches biotech hub to support life science progress

Drug Discovery World

Bios Health Group has launched the Bios Innovation Circle – a new venture studio and strategic hub, designed to support biotechnology and life science companies towards growing success. A real revolution in life science development.”

Science 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Partnership to advance life science professionals in drug discovery 

Drug Discovery World

The European Laboratory Research & Innovation Group (ELRIG) UK has entered into a partnership with SRG to support the advancement of science professionals in their careers.

Science 130
article thumbnail

International Women’s Day: Female life science leaders

Drug Discovery World

For International Women’s Day, DDW’s Diana Spencer celebrates some of the women in leadership making an impact on the drug discovery and life sciences sector. The life sciences sector has traditionally outperformed others when it comes to attracting women to its workforce. Anti-ageing science therefore has huge value.

article thumbnail

Journey Science : How Journey Science is Transforming Data Science and Customer Experience

Perficient: Drug Development

Computer Science, Data Science, Journey Science. Computer Science: The Here and Now In the beginning, Computer Science was abstract. This would let humans focus on functions that mattered more, like advancing science or the arts. Next, AI and Machine-Learning became critical capabilities for the Enterprise.

Science 98
article thumbnail

Gilead Sciences opens first research centre outside US

Drug Discovery World

Gilead Sciences has opened a new research site at the Business Park in Oxford, UK. Flavius Martin, Executive Vice President, Research, Gilead Sciences, said: “Our new Oxford site will enable us to continue our pivotal research in autoimmune conditions such as inflammatory bowel disease, rheumatoid arthritis and lupus.

Science 130
article thumbnail

Turning science into business: Amplifying mRNA by targeting regRNAs

Drug Discovery World

DDW’s Diana Spencer speaks to Josh Mandel-Brehm , CEO of Massachusetts-based biotech CAMP4, to understand the role regulatory RNAs play in gene expression and how the founders overcame the challenge of launching a business based on brand new science. JMB: Since the early days of CAMP4, we have always followed the science.

Science 147